Novavax, Inc.
NVAX
$5.96
-$0.23-3.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 220.06% | 65.60% | 48.11% | 49.84% | 65.49% |
| Total Depreciation and Amortization | 0.81% | 17.64% | 24.22% | 30.90% | 41.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.15% | -98.05% | -55.64% | -72.99% | -75.11% |
| Change in Net Operating Assets | -176.91% | 112.87% | 112.90% | 126.46% | -139.66% |
| Cash from Operations | 59.91% | 87.78% | 86.13% | 102.18% | 27.73% |
| Capital Expenditure | 81.89% | 75.72% | 70.62% | 50.62% | 55.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27,497.03% | -7,519.15% | -8,687.05% | -4,265.00% | 78.53% |
| Cash from Investing | -535.58% | -246.97% | -397.44% | -391.35% | 57.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -324.67% | 98.87% | 99.11% | 99.70% | 99.68% |
| Issuance of Common Stock | -29.54% | -26.40% | 12.36% | 326.09% | 421.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -588.96% | 100.00% | 100.00% | 100.00% | 93.51% |
| Cash from Financing | -32.10% | 5,734.82% | 281.50% | 523.60% | 292.72% |
| Foreign Exchange rate Adjustments | -166.46% | -338.39% | 26.33% | 48,273.68% | 268.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.22% | 94.97% | 87.59% | 120.43% | 85.11% |